DJ Inovio Pharmaceuticals Inc. Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. $(INO)$ rallied 1.52% to $2.00 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 2.47% to 19,199.16 and the Dow Jones Industrial Average rising 1.78% to 42,343.65.
Inovio Pharmaceuticals Inc. closed 83.78% below its 52-week high of $12.33, which the company reached on July 26th.
The stock outperformed some of its competitors Tuesday, as Johnson & Johnson $(JNJ)$ rose 1.06% to $153.25, Statera Biopharma Inc. (STAB) remained unchanged, and Pfizer Inc. $(PFE)$ rose 1.24% to $23.61.
Trading volume (455,089) remained 198,632 below its 50-day average volume of 653,721.
Data source: Dow Jones Market Data, FactSet. Data compiled May 27, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 27, 2025 17:28 ET (21:28 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。